TelomEYE Pharmaceutical
Developing innovative treatments to prevent, delay and cure age-related conditions of the eye. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€9m (Public information from Nov 2022)
Burlington Ontario (HQ)
Authorizing premium user...